The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...

Over 10 million infants under 6 months of age worldwide are at risk of poor growth and development (henceforth ‘infants u6m’). 1 Risks include short-term mortality and non-communicable disease in ...